Anti-TRAF6 monoclonal antibody

Pre-made anti-TRAF6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRAF6/TRAF6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T15051-Ab-1/ GM-Tg-hg-T15051-Ab-2Anti-Human TRAF6 monoclonal antibodyHuman
GM-Tg-rg-T15051-Ab-1/ GM-Tg-rg-T15051-Ab-2Anti-Rat TRAF6 monoclonal antibodyRat
GM-Tg-mg-T15051-Ab-1/ GM-Tg-mg-T15051-Ab-2Anti-Mouse TRAF6 monoclonal antibodyMouse
GM-Tg-cynog-T15051-Ab-1/ GM-Tg-cynog-T15051-Ab-2Anti-Cynomolgus/ Rhesus macaque TRAF6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T15051-Ab-1/ GM-Tg-felg-T15051-Ab-2Anti-Feline TRAF6 monoclonal antibodyFeline
GM-Tg-cang-T15051-Ab-1/ GM-Tg-cang-T15051-Ab-2Anti-Canine TRAF6 monoclonal antibodyCanine
GM-Tg-bovg-T15051-Ab-1/ GM-Tg-bovg-T15051-Ab-2Anti-Bovine TRAF6 monoclonal antibodyBovine
GM-Tg-equg-T15051-Ab-1/ GM-Tg-equg-T15051-Ab-2Anti-Equine TRAF6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T15051-Ab-1/ GM-Tg-hg-T15051-Ab-2; GM-Tg-rg-T15051-Ab-1/ GM-Tg-rg-T15051-Ab-2;
GM-Tg-mg-T15051-Ab-1/ GM-Tg-mg-T15051-Ab-2; GM-Tg-cynog-T15051-Ab-1/ GM-Tg-cynog-T15051-Ab-2;
GM-Tg-felg-T15051-Ab-1/ GM-Tg-felg-T15051-Ab-2; GM-Tg-cang-T15051-Ab-1/ GM-Tg-cang-T15051-Ab-2;
GM-Tg-bovg-T15051-Ab-1/ GM-Tg-bovg-T15051-Ab-2; GM-Tg-equg-T15051-Ab-1/ GM-Tg-equg-T15051-Ab-2
Products NameAnti-TRAF6 monoclonal antibody
Formatmab
Target NameTRAF6
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRAF6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T15051-Ag-1Recombinant multi-species TRAF6/ MGC:3310/ RNF85 protein
    CytokineGM-Tg-g-T15051-Ag-1TNF receptor-associated factor 6, E3 ubiquitin protein ligase (TRAF6) protein
    ORF Viral VectorpGMLP001351human NM_145803humanNM_145803 Lentivirus plasmid
    ORF Viral VectorvGMLP001351human NM_145803humanNM_145803 Lentivirus particle
    ORF Viral VectorpGMAD000221mouse Traf6 Adenovirus plasmid
    ORF Viral VectorpGMLPm001259mouse Traf6 Lentivirus plasmid
    ORF Viral VectorpGMLPm005412mouse Traf6 Lentivirus plasmid
    ORF Viral VectorvGMAD000221mouse Traf6 Adenovirus particle
    ORF Viral VectorvGMLPm001259mouse Traf6 Lentivirus particle
    ORF Viral VectorvGMLPm005412mouse Traf6 Lentivirus particle


    Target information

    Target IDGM-T15051
    Target NameTRAF6
    Gene ID7189,22034,311245,716907,100688110,101099750,539124,100052296
    Gene Symbol and Synonyms2310003F17Rik,C630032O20Rik,MGC:3310,RNF85,TRAF6
    Uniprot AccessionQ9Y4K3,B5DF45,B6CJY5,Q3ZCC3
    Uniprot Entry NameTRAF6_HUMAN,TRAF6_MACMU,TRAF6_RAT,TRAF6_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Cytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000175104
    Target ClassificationTumor-associated antigen (TAA)

    The target: TRAF6, gene name: TRAF6, also named as MGC:3310, RNF85. The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.